Klein S - Search Results

1

In vitro tools for evaluating novel dosage forms of poorly soluble, weakly basic drugs: case example ketoconazole.

Taupitz T, Dressman JB, Klein S. Taupitz T, et al. Among authors: klein s. J Pharm Sci. 2013 Oct;102(10):3645-52. doi: 10.1002/jps.23666. Epub 2013 Jul 19. J Pharm Sci. 2013. PMID: 23873592

2

A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis.

Rudolph MW, Klein S, Beckert TE, Petereit H, Dressman JB. Rudolph MW, et al. Among authors: klein s. Eur J Pharm Biopharm. 2001 May;51(3):183-90. doi: 10.1016/s0939-6411(01)00134-5. Eur J Pharm Biopharm. 2001. PMID: 11343881

3

Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts.

Klein S, Butler J, Hempenstall JM, Reppas C, Dressman JB. Klein S, et al. J Pharm Pharmacol. 2004 May;56(5):605-10. doi: 10.1211/0022357023367. J Pharm Pharmacol. 2004. PMID: 15142337

4

Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model.

Klein S, Stein J, Dressman J. Klein S, et al. J Pharm Pharmacol. 2005 Jun;57(6):709-19. doi: 10.1211/0022357056172. J Pharm Pharmacol. 2005. PMID: 15969925

5

Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.

Buchanan CM, Buchanan NL, Edgar KJ, Klein S, Little JL, Ramsey MG, Ruble KM, Wacher VJ, Wempe MF. Buchanan CM, et al. Among authors: klein s. J Pharm Sci. 2007 Nov;96(11):3100-16. doi: 10.1002/jps.20878. J Pharm Sci. 2007. PMID: 17712849

6

Use of the BioDis to generate a physiologically relevant IVIVC.

Klein S, Rudolph MW, Skalsky B, Petereit HU, Dressman JB. Klein S, et al. J Control Release. 2008 Sep 24;130(3):216-9. doi: 10.1016/j.jconrel.2008.06.014. Epub 2008 Jun 23. J Control Release. 2008. PMID: 18621090

7

A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets.

Abdalla A, Klein S, Mäder K. Abdalla A, et al. Among authors: klein s. Eur J Pharm Sci. 2008 Dec 18;35(5):457-64. doi: 10.1016/j.ejps.2008.09.006. Epub 2008 Oct 1. Eur J Pharm Sci. 2008. PMID: 18940249

8

Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.

Klein S, Wempe MF, Zoeller T, Buchanan NL, Lambert JL, Ramsey MG, Edgar KJ, Buchanan CM. Klein S, et al. J Pharm Pharmacol. 2009 Jan;61(1):23-30. doi: 10.1211/jpp/61.01.0004. J Pharm Pharmacol. 2009. PMID: 19126293

9

A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations.

Fotaki N, Aivaliotis A, Butler J, Dressman J, Fischbach M, Hempenstall J, Klein S, Reppas C. Fotaki N, et al. Among authors: klein s. Eur J Pharm Biopharm. 2009 Sep;73(1):115-20. doi: 10.1016/j.ejpb.2009.04.012. Epub 2009 May 13. Eur J Pharm Biopharm. 2009. PMID: 19442728

10

Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.

Zoeller T, Dressman JB, Klein S. Zoeller T, et al. Among authors: klein s. Int J Pharm. 2012 Jul 1;430(1-2):176-83. doi: 10.1016/j.ijpharm.2012.04.029. Epub 2012 Apr 15. Int J Pharm. 2012. PMID: 22531855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,771 results

Search Page

Filters